Global Non-small Cell Lung Cancer Therapeutics Market Research Report 2018

June 2018 | 94 pages | ID: G3A2290EBFFEN
QYResearch

Abstracts

This report studies the global Non-small Cell Lung Cancer Therapeutics market status and forecast, categorizes the global Non-small Cell Lung Cancer Therapeutics market size (value & volume) by key players, type, application, and region.
This report focuses on the top players in North America, Europe, Asia-Pacific, South America, and Middle East & Africa.
Non-small-cell lung carcinoma (NSCLC) is any type of epithelial lung cancer other than small cell lung carcinoma (SCLC). NSCLC accounts for about 85% of all lung cancers.

The global Non-small Cell Lung Cancer Therapeutics market is valued at 6660 million US$ in 2017 and will reach 11900 million US$ by the end of 2025, growing at a CAGR of 7.5% during 2018-2025.

The major manufacturers covered in this report

• GlaxoSmithKline
• Novartis
• AstraZeneca
• Roche
• Bristol-Myers Squibb
• Pfizer
• Eli Lilly
• Sanofi

Geographically, this report studies the key regions, focuses on product sales, value, market share and growth opportunity in these regions, covering

• North America
• Europe
• China
• Japan
• Southeast Asia
• India

We can also provide the customized separate regional or country-level reports, for the following regions:

• North America
• United States
• Canada
• Mexico
• Asia-Pacific
• China
• India
• Japan
• South Korea
• Australia
• Indonesia
• Singapore
• Rest of Asia-Pacific
• Europe
• Germany
• France
• UK
• Italy
• Spain
• Russia
• Rest of Europe
• Central & South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Saudi Arabia
• Turkey
• Rest of Middle East & Africa

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• Alimta
• Iressa
• Avastin
• Tarceva
• Zykadia
• Tagrisso
• Xalkori
• Cyramza
• Opdivo
• Alecensa

On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including

• Hospital
• Clinic

The study objectives of this report are:

• To analyze and study the global Non-small Cell Lung Cancer Therapeutics sales, value, status (2013-2017) and forecast (2018-2025).
• Focuses on the key Non-small Cell Lung Cancer Therapeutics manufacturers, to study the sales, value, market share and development plans in future.
• Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
• To define, describe and forecast the market by type, application and region.
• To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
• To identify significant trends and factors driving or inhibiting the market growth.
• To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
• To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
• To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
• To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Non-small Cell Lung Cancer Therapeutics are as follows:

• History Year: 2013-2017
• Base Year: 2017
• Estimated Year: 2018
• Forecast Year 2018 to 2025

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Key Stakeholders
Non-small Cell Lung Cancer Therapeutics Manufacturers
Non-small Cell Lung Cancer Therapeutics Distributors/Traders/Wholesalers
Non-small Cell Lung Cancer Therapeutics Subcomponent Manufacturers
Industry Association
Downstream Vendors
Available Customizations
With the given market data, QYResearch offers customizations according to the company's specific needs. The following customization options are available for the report:
Regional and country-level analysis of the Non-small Cell Lung Cancer Therapeutics market, by end-use.
Detailed analysis and profiles of additional market players.

Contents

Global Non-small Cell Lung Cancer Therapeutics Market Research Report 2018

1 NON-SMALL CELL LUNG CANCER THERAPEUTICS MARKET OVERVIEW

1.1 Product Overview and Scope of Non-small Cell Lung Cancer Therapeutics
1.2 Non-small Cell Lung Cancer Therapeutics Segment by Type (Product Category)
  1.2.1 Global Non-small Cell Lung Cancer Therapeutics Production and CAGR (%) Comparison by Type (Product Category)(2013-2025)
  1.2.2 Global Non-small Cell Lung Cancer Therapeutics Production Market Share by Type (Product Category) in 2017
  1.2.3 Alimta
  1.2.4 Iressa
  1.2.5 Avastin
  1.2.6 Tarceva
  1.2.7 Zykadia
  1.2.8 Tagrisso
  1.2.9 Xalkori
  1.2.10 Cyramza
  1.2.11 Opdivo
  1.2.12 Alecensa
1.3 Global Non-small Cell Lung Cancer Therapeutics Segment by Application
  1.3.1 Non-small Cell Lung Cancer Therapeutics Consumption (Sales) Comparison by Application (2013-2025)
  1.3.2 Hospital
  1.3.3 Clinic
1.4 Global Non-small Cell Lung Cancer Therapeutics Market by Region (2013-2025)
  1.4.1 Global Non-small Cell Lung Cancer Therapeutics Market Size (Value) and CAGR (%) Comparison by Region (2013-2025)
  1.4.2 North America Status and Prospect (2013-2025)
  1.4.3 Europe Status and Prospect (2013-2025)
  1.4.4 China Status and Prospect (2013-2025)
  1.4.5 Japan Status and Prospect (2013-2025)
  1.4.6 Southeast Asia Status and Prospect (2013-2025)
  1.4.7 India Status and Prospect (2013-2025)
1.5 Global Market Size (Value) of Non-small Cell Lung Cancer Therapeutics (2013-2025)
  1.5.1 Global Non-small Cell Lung Cancer Therapeutics Revenue Status and Outlook (2013-2025)
  1.5.2 Global Non-small Cell Lung Cancer Therapeutics Capacity, Production Status and Outlook (2013-2025)

2 GLOBAL NON-SMALL CELL LUNG CANCER THERAPEUTICS MARKET COMPETITION BY MANUFACTURERS

2.1 Global Non-small Cell Lung Cancer Therapeutics Capacity, Production and Share by Manufacturers (2013-2018)
  2.1.1 Global Non-small Cell Lung Cancer Therapeutics Capacity and Share by Manufacturers (2013-2018)
  2.1.2 Global Non-small Cell Lung Cancer Therapeutics Production and Share by Manufacturers (2013-2018)
2.2 Global Non-small Cell Lung Cancer Therapeutics Revenue and Share by Manufacturers (2013-2018)
2.3 Global Non-small Cell Lung Cancer Therapeutics Average Price by Manufacturers (2013-2018)
2.4 Manufacturers Non-small Cell Lung Cancer Therapeutics Manufacturing Base Distribution, Sales Area and Product Type
2.5 Non-small Cell Lung Cancer Therapeutics Market Competitive Situation and Trends
  2.5.1 Non-small Cell Lung Cancer Therapeutics Market Concentration Rate
  2.5.2 Non-small Cell Lung Cancer Therapeutics Market Share of Top 3 and Top 5 Manufacturers
  2.5.3 Mergers & Acquisitions, Expansion

3 GLOBAL NON-SMALL CELL LUNG CANCER THERAPEUTICS CAPACITY, PRODUCTION, REVENUE (VALUE) BY REGION (2013-2018)

3.1 Global Non-small Cell Lung Cancer Therapeutics Capacity and Market Share by Region (2013-2018)
3.2 Global Non-small Cell Lung Cancer Therapeutics Production and Market Share by Region (2013-2018)
3.3 Global Non-small Cell Lung Cancer Therapeutics Revenue (Value) and Market Share by Region (2013-2018)
3.4 Global Non-small Cell Lung Cancer Therapeutics Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.5 North America Non-small Cell Lung Cancer Therapeutics Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.6 Europe Non-small Cell Lung Cancer Therapeutics Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.7 China Non-small Cell Lung Cancer Therapeutics Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.8 Japan Non-small Cell Lung Cancer Therapeutics Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.9 Southeast Asia Non-small Cell Lung Cancer Therapeutics Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.10 India Non-small Cell Lung Cancer Therapeutics Capacity, Production, Revenue, Price and Gross Margin (2013-2018)

4 GLOBAL NON-SMALL CELL LUNG CANCER THERAPEUTICS SUPPLY (PRODUCTION), CONSUMPTION, EXPORT, IMPORT BY REGION (2013-2018)

4.1 Global Non-small Cell Lung Cancer Therapeutics Consumption by Region (2013-2018)
4.2 North America Non-small Cell Lung Cancer Therapeutics Production, Consumption, Export, Import (2013-2018)
4.3 Europe Non-small Cell Lung Cancer Therapeutics Production, Consumption, Export, Import (2013-2018)
4.4 China Non-small Cell Lung Cancer Therapeutics Production, Consumption, Export, Import (2013-2018)
4.5 Japan Non-small Cell Lung Cancer Therapeutics Production, Consumption, Export, Import (2013-2018)
4.6 Southeast Asia Non-small Cell Lung Cancer Therapeutics Production, Consumption, Export, Import (2013-2018)
4.7 India Non-small Cell Lung Cancer Therapeutics Production, Consumption, Export, Import (2013-2018)

5 GLOBAL NON-SMALL CELL LUNG CANCER THERAPEUTICS PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE

5.1 Global Non-small Cell Lung Cancer Therapeutics Production and Market Share by Type (2013-2018)
5.2 Global Non-small Cell Lung Cancer Therapeutics Revenue and Market Share by Type (2013-2018)
5.3 Global Non-small Cell Lung Cancer Therapeutics Price by Type (2013-2018)
5.4 Global Non-small Cell Lung Cancer Therapeutics Production Growth by Type (2013-2018)

6 GLOBAL NON-SMALL CELL LUNG CANCER THERAPEUTICS MARKET ANALYSIS BY APPLICATION

6.1 Global Non-small Cell Lung Cancer Therapeutics Consumption and Market Share by Application (2013-2018)
6.2 Global Non-small Cell Lung Cancer Therapeutics Consumption Growth Rate by Application (2013-2018)
6.3 Market Drivers and Opportunities
  6.3.1 Potential Applications
  6.3.2 Emerging Markets/Countries

7 GLOBAL NON-SMALL CELL LUNG CANCER THERAPEUTICS MANUFACTURERS PROFILES/ANALYSIS

7.1 GlaxoSmithKline
  7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.1.2 Non-small Cell Lung Cancer Therapeutics Product Category, Application and Specification
    7.1.2.1 Product A
    7.1.2.2 Product B
  7.1.3 GlaxoSmithKline Non-small Cell Lung Cancer Therapeutics Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
  7.1.4 Main Business/Business Overview
7.2 Novartis
  7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.2.2 Non-small Cell Lung Cancer Therapeutics Product Category, Application and Specification
    7.2.2.1 Product A
    7.2.2.2 Product B
  7.2.3 Novartis Non-small Cell Lung Cancer Therapeutics Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
  7.2.4 Main Business/Business Overview
7.3 AstraZeneca
  7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.3.2 Non-small Cell Lung Cancer Therapeutics Product Category, Application and Specification
    7.3.2.1 Product A
    7.3.2.2 Product B
  7.3.3 AstraZeneca Non-small Cell Lung Cancer Therapeutics Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
  7.3.4 Main Business/Business Overview
7.4 Roche
  7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.4.2 Non-small Cell Lung Cancer Therapeutics Product Category, Application and Specification
    7.4.2.1 Product A
    7.4.2.2 Product B
  7.4.3 Roche Non-small Cell Lung Cancer Therapeutics Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
  7.4.4 Main Business/Business Overview
7.5 Bristol-Myers Squibb
  7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.5.2 Non-small Cell Lung Cancer Therapeutics Product Category, Application and Specification
    7.5.2.1 Product A
    7.5.2.2 Product B
  7.5.3 Bristol-Myers Squibb Non-small Cell Lung Cancer Therapeutics Capacity, Production, Revenue, Price and Gross Margin (2015-2018)
  7.5.4 Main Business/Business Overview
7.6 Pfizer
  7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.6.2 Non-small Cell Lung Cancer Therapeutics Product Category, Application and Specification
    7.6.2.1 Product A
    7.6.2.2 Product B
  7.6.3 Pfizer Non-small Cell Lung Cancer Therapeutics Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
  7.6.4 Main Business/Business Overview
7.7 Eli Lilly
  7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.7.2 Non-small Cell Lung Cancer Therapeutics Product Category, Application and Specification
    7.7.2.1 Product A
    7.7.2.2 Product B
  7.7.3 Eli Lilly Non-small Cell Lung Cancer Therapeutics Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
  7.7.4 Main Business/Business Overview
7.8 Sanofi
  7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.8.2 Non-small Cell Lung Cancer Therapeutics Product Category, Application and Specification
    7.8.2.1 Product A
    7.8.2.2 Product B
  7.8.3 Sanofi Non-small Cell Lung Cancer Therapeutics Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
  7.8.4 Main Business/Business Overview

8 NON-SMALL CELL LUNG CANCER THERAPEUTICS MANUFACTURING COST ANALYSIS

8.1 Non-small Cell Lung Cancer Therapeutics Key Raw Materials Analysis
  8.1.1 Key Raw Materials
  8.1.2 Price Trend of Key Raw Materials
  8.1.3 Key Suppliers of Raw Materials
  8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
  8.2.1 Raw Materials
  8.2.2 Labor Cost
  8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Non-small Cell Lung Cancer Therapeutics

9 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

9.1 Non-small Cell Lung Cancer Therapeutics Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Non-small Cell Lung Cancer Therapeutics Major Manufacturers in 2017
9.4 Downstream Buyers

10 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

10.1 Marketing Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
  10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
  10.2.1 Pricing Strategy
  10.2.2 Brand Strategy
  10.2.3 Target Client
10.3 Distributors/Traders List

11 MARKET EFFECT FACTORS ANALYSIS

11.1 Technology Progress/Risk
  11.1.1 Substitutes Threat
  11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

12 GLOBAL NON-SMALL CELL LUNG CANCER THERAPEUTICS MARKET FORECAST (2018-2025)

12.1 Global Non-small Cell Lung Cancer Therapeutics Capacity, Production, Revenue Forecast (2018-2025)
  12.1.1 Global Non-small Cell Lung Cancer Therapeutics Capacity, Production and Growth Rate Forecast (2018-2025)
  12.1.2 Global Non-small Cell Lung Cancer Therapeutics Revenue and Growth Rate Forecast (2018-2025)
  12.1.3 Global Non-small Cell Lung Cancer Therapeutics Price and Trend Forecast (2018-2025)
12.2 Global Non-small Cell Lung Cancer Therapeutics Production, Consumption, Import and Export Forecast by Region (2018-2025)
  12.2.1 North America Non-small Cell Lung Cancer Therapeutics Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
  12.2.2 Europe Non-small Cell Lung Cancer Therapeutics Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
  12.2.3 China Non-small Cell Lung Cancer Therapeutics Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
  12.2.4 Japan Non-small Cell Lung Cancer Therapeutics Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
  12.2.5 Southeast Asia Non-small Cell Lung Cancer Therapeutics Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
  12.2.6 India Non-small Cell Lung Cancer Therapeutics Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
12.3 Global Non-small Cell Lung Cancer Therapeutics Production, Revenue and Price Forecast by Type (2018-2025)
12.4 Global Non-small Cell Lung Cancer Therapeutics Consumption Forecast by Application (2018-2025)

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

14.1 Methodology/Research Approach
  14.1.1 Research Programs/Design
  14.1.2 Market Size Estimation
  14.1.3 Market Breakdown and Data Triangulation
14.2 Data Source
  14.2.1 Secondary Sources
  14.2.2 Primary Sources
14.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Non-small Cell Lung Cancer Therapeutics
Figure Global Non-small Cell Lung Cancer Therapeutics Production () and CAGR (%) Comparison by Types (Product Category) (2013-2025)
Figure Global Non-small Cell Lung Cancer Therapeutics Production Market Share by Types (Product Category) in 2017
Figure Product Picture of Alimta
Table Major Manufacturers of Alimta
Figure Product Picture of Iressa
Table Major Manufacturers of Iressa
Figure Product Picture of Avastin
Table Major Manufacturers of Avastin
Figure Product Picture of Tarceva
Table Major Manufacturers of Tarceva
Figure Product Picture of Zykadia
Table Major Manufacturers of Zykadia
Figure Product Picture of Tagrisso
Table Major Manufacturers of Tagrisso
Figure Product Picture of Xalkori
Table Major Manufacturers of Xalkori
Figure Product Picture of Cyramza
Table Major Manufacturers of Cyramza
Figure Product Picture of Opdivo
Table Major Manufacturers of Opdivo
Figure Product Picture of Alecensa
Table Major Manufacturers of Alecensa
Figure Global Non-small Cell Lung Cancer Therapeutics Consumption (K Units) by Applications (2013-2025)
Figure Global Non-small Cell Lung Cancer Therapeutics Consumption Market Share by Applications in 2017
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure Clinic Examples
Table Key Downstream Customer in Clinic
Figure Global Non-small Cell Lung Cancer Therapeutics Market Size (Million USD), Comparison (K Units) and CAGR (%) by Regions (2013-2025)
Figure North America Non-small Cell Lung Cancer Therapeutics Revenue (Million USD) and Growth Rate (2013-2025)
Figure Europe Non-small Cell Lung Cancer Therapeutics Revenue (Million USD) and Growth Rate (2013-2025)
Figure China Non-small Cell Lung Cancer Therapeutics Revenue (Million USD) and Growth Rate (2013-2025)
Figure Japan Non-small Cell Lung Cancer Therapeutics Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southeast Asia Non-small Cell Lung Cancer Therapeutics Revenue (Million USD) and Growth Rate (2013-2025)
Figure India Non-small Cell Lung Cancer Therapeutics Revenue (Million USD) and Growth Rate (2013-2025)
Figure Global Non-small Cell Lung Cancer Therapeutics Revenue (Million USD) Status and Outlook (2013-2025)
Figure Global Non-small Cell Lung Cancer Therapeutics Capacity, Production (K Units) Status and Outlook (2013-2025)
Figure Global Non-small Cell Lung Cancer Therapeutics Major Players Product Capacity (K Units) (2013-2018)
Table Global Non-small Cell Lung Cancer Therapeutics Capacity (K Units) of Key Manufacturers (2013-2018)
Table Global Non-small Cell Lung Cancer Therapeutics Capacity Market Share of Key Manufacturers (2013-2018)
Figure Global Non-small Cell Lung Cancer Therapeutics Capacity (K Units) of Key Manufacturers in 2017
Figure Global Non-small Cell Lung Cancer Therapeutics Capacity (K Units) of Key Manufacturers in 2018
Figure Global Non-small Cell Lung Cancer Therapeutics Major Players Product Production (K Units) (2013-2018)
Table Global Non-small Cell Lung Cancer Therapeutics Production (K Units) of Key Manufacturers (2013-2018)
Table Global Non-small Cell Lung Cancer Therapeutics Production Share by Manufacturers (2013-2018)
Figure 2017 Non-small Cell Lung Cancer Therapeutics Production Share by Manufacturers
Figure 2017 Non-small Cell Lung Cancer Therapeutics Production Share by Manufacturers
Figure Global Non-small Cell Lung Cancer Therapeutics Major Players Product Revenue (Million USD) (2013-2018)
Table Global Non-small Cell Lung Cancer Therapeutics Revenue (Million USD) by Manufacturers (2013-2018)
Table Global Non-small Cell Lung Cancer Therapeutics Revenue Share by Manufacturers (2013-2018)
Table 2017 Global Non-small Cell Lung Cancer Therapeutics Revenue Share by Manufacturers
Table 2018 Global Non-small Cell Lung Cancer Therapeutics Revenue Share by Manufacturers
Table Global Market Non-small Cell Lung Cancer Therapeutics Average Price (USD/Unit) of Key Manufacturers (2013-2018)
Figure Global Market Non-small Cell Lung Cancer Therapeutics Average Price (USD/Unit) of Key Manufacturers in 2017
Table Manufacturers Non-small Cell Lung Cancer Therapeutics Manufacturing Base Distribution and Sales Area
Table Manufacturers Non-small Cell Lung Cancer Therapeutics Product Category
Figure Non-small Cell Lung Cancer Therapeutics Market Share of Top 3 Manufacturers
Figure Non-small Cell Lung Cancer Therapeutics Market Share of Top 5 Manufacturers
Table Global Non-small Cell Lung Cancer Therapeutics Capacity (K Units) by Region (2013-2018)
Figure Global Non-small Cell Lung Cancer Therapeutics Capacity Market Share by Region (2013-2018)
Figure Global Non-small Cell Lung Cancer Therapeutics Capacity Market Share by Region (2013-2018)
Figure 2017 Global Non-small Cell Lung Cancer Therapeutics Capacity Market Share by Region
Table Global Non-small Cell Lung Cancer Therapeutics Production by Region (2013-2018)
Figure Global Non-small Cell Lung Cancer Therapeutics Production (K Units) by Region (2013-2018)
Figure Global Non-small Cell Lung Cancer Therapeutics Production Market Share by Region (2013-2018)
Figure 2017 Global Non-small Cell Lung Cancer Therapeutics Production Market Share by Region
Table Global Non-small Cell Lung Cancer Therapeutics Revenue (Million USD) by Region (2013-2018)
Table Global Non-small Cell Lung Cancer Therapeutics Revenue Market Share by Region (2013-2018)
Figure Global Non-small Cell Lung Cancer Therapeutics Revenue Market Share by Region (2013-2018)
Table 2017 Global Non-small Cell Lung Cancer Therapeutics Revenue Market Share by Region
Figure Global Non-small Cell Lung Cancer Therapeutics Capacity, Production (K Units) and Growth Rate (2013-2018)
Table Global Non-small Cell Lung Cancer Therapeutics Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table North America Non-small Cell Lung Cancer Therapeutics Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table Europe Non-small Cell Lung Cancer Therapeutics Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table China Non-small Cell Lung Cancer Therapeutics Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table Japan Non-small Cell Lung Cancer Therapeutics Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table China Non-small Cell Lung Cancer Therapeutics Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table Japan Non-small Cell Lung Cancer Therapeutics Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Table Global Non-small Cell Lung Cancer Therapeutics Consumption (K Units) Market by Region (2013-2018)
Table Global Non-small Cell Lung Cancer Therapeutics Consumption Market Share by Region (2013-2018)
Figure Global Non-small Cell Lung Cancer Therapeutics Consumption Market Share by Region (2013-2018)
Figure 2017 Global Non-small Cell Lung Cancer Therapeutics Consumption (K Units) Market Share by Region
Table North America Non-small Cell Lung Cancer Therapeutics Production, Consumption, Import & Export (K Units) (2013-2018)
Table Europe Non-small Cell Lung Cancer Therapeutics Production, Consumption, Import & Export (K Units) (2013-2018)
Table China Non-small Cell Lung Cancer Therapeutics Production, Consumption, Import & Export (K Units) (2013-2018)
Table Japan Non-small Cell Lung Cancer Therapeutics Production, Consumption, Import & Export (K Units) (2013-2018)
Table Southeast Asia Non-small Cell Lung Cancer Therapeutics Production, Consumption, Import & Export (K Units) (2013-2018)
Table India Non-small Cell Lung Cancer Therapeutics Production, Consumption, Import & Export (K Units) (2013-2018)
Table Global Non-small Cell Lung Cancer Therapeutics Production (K Units) by Type (2013-2018)
Table Global Non-small Cell Lung Cancer Therapeutics Production Share by Type (2013-2018)
Figure Production Market Share of Non-small Cell Lung Cancer Therapeutics by Type (2013-2018)
Figure 2017 Production Market Share of Non-small Cell Lung Cancer Therapeutics by Type
Table Global Non-small Cell Lung Cancer Therapeutics Revenue (Million USD) by Type (2013-2018)
Table Global Non-small Cell Lung Cancer Therapeutics Revenue Share by Type (2013-2018)
Figure Production Revenue Share of Non-small Cell Lung Cancer Therapeutics by Type (2013-2018)
Figure 2017 Revenue Market Share of Non-small Cell Lung Cancer Therapeutics by Type
Table Global Non-small Cell Lung Cancer Therapeutics Price (USD/Unit) by Type (2013-2018)
Figure Global Non-small Cell Lung Cancer Therapeutics Production Growth by Type (2013-2018)
Table Global Non-small Cell Lung Cancer Therapeutics Consumption (K Units) by Application (2013-2018)
Table Global Non-small Cell Lung Cancer Therapeutics Consumption Market Share by Application (2013-2018)
Figure Global Non-small Cell Lung Cancer Therapeutics Consumption Market Share by Applications (2013-2018)
Figure Global Non-small Cell Lung Cancer Therapeutics Consumption Market Share by Application in 2017
Table Global Non-small Cell Lung Cancer Therapeutics Consumption Growth Rate by Application (2013-2018)
Figure Global Non-small Cell Lung Cancer Therapeutics Consumption Growth Rate by Application (2013-2018)
Table GlaxoSmithKline Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table GlaxoSmithKline Non-small Cell Lung Cancer Therapeutics Capacity, Production (K Units), Revenue (Million USD), Price (GlaxoSmithKline) and Gross Margin (2013-2018)
Figure GlaxoSmithKline Non-small Cell Lung Cancer Therapeutics Production Growth Rate (2013-2018)
Figure GlaxoSmithKline Non-small Cell Lung Cancer Therapeutics Production Market Share (2013-2018)
Figure GlaxoSmithKline Non-small Cell Lung Cancer Therapeutics Revenue Market Share (2013-2018)
Table Novartis Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Novartis Non-small Cell Lung Cancer Therapeutics Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Novartis Non-small Cell Lung Cancer Therapeutics Production Growth Rate (2013-2018)
Figure Novartis Non-small Cell Lung Cancer Therapeutics Production Market Share (2013-2018)
Figure Novartis Non-small Cell Lung Cancer Therapeutics Revenue Market Share (2013-2018)
Table AstraZeneca Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table AstraZeneca Non-small Cell Lung Cancer Therapeutics Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure AstraZeneca Non-small Cell Lung Cancer Therapeutics Production Growth Rate (2013-2018)
Figure AstraZeneca Non-small Cell Lung Cancer Therapeutics Production Market Share (2013-2018)
Figure AstraZeneca Non-small Cell Lung Cancer Therapeutics Revenue Market Share (2013-2018)
Table Roche Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Roche Non-small Cell Lung Cancer Therapeutics Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Roche Non-small Cell Lung Cancer Therapeutics Production Growth Rate (2013-2018)
Figure Roche Non-small Cell Lung Cancer Therapeutics Production Market Share (2013-2018)
Figure Roche Non-small Cell Lung Cancer Therapeutics Revenue Market Share (2013-2018)
Table Bristol-Myers Squibb Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Bristol-Myers Squibb Non-small Cell Lung Cancer Therapeutics Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Bristol-Myers Squibb Non-small Cell Lung Cancer Therapeutics Production Growth Rate (2013-2018)
Figure Bristol-Myers Squibb Non-small Cell Lung Cancer Therapeutics Production Market Share (2013-2018)
Figure Bristol-Myers Squibb Non-small Cell Lung Cancer Therapeutics Revenue Market Share (2013-2018)
Table Pfizer Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Pfizer Non-small Cell Lung Cancer Therapeutics Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Pfizer Non-small Cell Lung Cancer Therapeutics Production Growth Rate (2013-2018)
Figure Pfizer Non-small Cell Lung Cancer Therapeutics Production Market Share (2013-2018)
Figure Pfizer Non-small Cell Lung Cancer Therapeutics Revenue Market Share (2013-2018)
Table Eli Lilly Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Eli Lilly Non-small Cell Lung Cancer Therapeutics Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Eli Lilly Non-small Cell Lung Cancer Therapeutics Production Growth Rate (2013-2018)
Figure Eli Lilly Non-small Cell Lung Cancer Therapeutics Production Market Share (2013-2018)
Figure Eli Lilly Non-small Cell Lung Cancer Therapeutics Revenue Market Share (2013-2018)
Table Sanofi Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Sanofi Non-small Cell Lung Cancer Therapeutics Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Sanofi Non-small Cell Lung Cancer Therapeutics Production Growth Rate (2013-2018)
Figure Sanofi Non-small Cell Lung Cancer Therapeutics Production Market Share (2013-2018)
Figure Sanofi Non-small Cell Lung Cancer Therapeutics Revenue Market Share (2013-2018)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Non-small Cell Lung Cancer Therapeutics
Figure Manufacturing Process Analysis of Non-small Cell Lung Cancer Therapeutics
Figure Non-small Cell Lung Cancer Therapeutics Industrial Chain Analysis
Table Raw Materials Sources of Non-small Cell Lung Cancer Therapeutics Major Manufacturers in 2017
Table Major Buyers of Non-small Cell Lung Cancer Therapeutics
Table Distributors/Traders List
Figure Global Non-small Cell Lung Cancer Therapeutics Capacity, Production (K Units) and Growth Rate Forecast (2018-2025)
Figure Global Non-small Cell Lung Cancer Therapeutics Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Global Non-small Cell Lung Cancer Therapeutics Price (Million USD) and Trend Forecast (2018-2025)
Table Global Non-small Cell Lung Cancer Therapeutics Production (K Units) Forecast by Region (2018-2025)
Figure Global Non-small Cell Lung Cancer Therapeutics Production Market Share Forecast by Region (2018-2025)
Table Global Non-small Cell Lung Cancer Therapeutics Consumption (K Units) Forecast by Region (2018-2025)
Figure Global Non-small Cell Lung Cancer Therapeutics Consumption Market Share Forecast by Region (2018-2025)
Figure North America Non-small Cell Lung Cancer Therapeutics Production (K Units) and Growth Rate Forecast (2018-2025)
Figure North America Non-small Cell Lung Cancer Therapeutics Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table North America Non-small Cell Lung Cancer Therapeutics Production, Consumption, Export and Import (K Units) Forecast (2018-2025)
Figure Europe Non-small Cell Lung Cancer Therapeutics Production (K Units) and Growth Rate Forecast (2018-2025)
Figure Europe Non-small Cell Lung Cancer Therapeutics Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table Europe Non-small Cell Lung Cancer Therapeutics Production, Consumption, Export and Import (K Units) Forecast (2018-2025)
Figure China Non-small Cell Lung Cancer Therapeutics Production (K Units) and Growth Rate Forecast (2018-2025)
Figure China Non-small Cell Lung Cancer Therapeutics Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table China Non-small Cell Lung Cancer Therapeutics Production, Consumption, Export and Import (K Units) Forecast (2018-2025)
Figure Japan Non-small Cell Lung Cancer Therapeutics Production (K Units) and Growth Rate Forecast (2018-2025)
Figure Japan Non-small Cell Lung Cancer Therapeutics Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table Japan Non-small Cell Lung Cancer Therapeutics Production, Consumption, Export and Import (K Units) Forecast (2018-2025)
Figure Southeast Asia Non-small Cell Lung Cancer Therapeutics Production (K Units) and Growth Rate Forecast (2018-2025)
Figure Southeast Asia Non-small Cell Lung Cancer Therapeutics Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table Southeast Asia Non-small Cell Lung Cancer Therapeutics Production, Consumption, Export and Import (K Units) Forecast (2018-2025)
Figure India Non-small Cell Lung Cancer Therapeutics Production (K Units) and Growth Rate Forecast (2018-2025)
Figure India Non-small Cell Lung Cancer Therapeutics Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table India Non-small Cell Lung Cancer Therapeutics Production, Consumption, Export and Import (K Units) Forecast (2018-2025)
Table Global Non-small Cell Lung Cancer Therapeutics Production (K Units) Forecast by Type (2018-2025)
Figure Global Non-small Cell Lung Cancer Therapeutics Production (K Units) Forecast by Type (2018-2025)
Table Global Non-small Cell Lung Cancer Therapeutics Revenue (Million USD) Forecast by Type (2018-2025)
Figure Global Non-small Cell Lung Cancer Therapeutics Revenue Market Share Forecast by Type (2018-2025)
Table Global Non-small Cell Lung Cancer Therapeutics Price Forecast by Type (2018-2025)
Table Global Non-small Cell Lung Cancer Therapeutics Consumption (K Units) Forecast by Application (2018-2025)
Figure Global Non-small Cell Lung Cancer Therapeutics Consumption (K Units) Forecast by Application (2018-2025)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Source